High levels of satisfaction, and low levels of regret, after gender affirming mastectomy

A study seeks to determine post surgery outcomes from patients

11:00 AM

Author | Valerie Goodwin

Blurry Operating Room
Getty Images

Gender affirming mastectomies for transmasculine and nonbinary individuals can be life changing.

Recent research from the University of Michigan finds that in addition to changing lives, most patients are highly satisfied with their decision to undergo surgery longterm.  

The study published in JAMA Surgery aimed to determine how patients who received a gender affirming mastectomy at a single major health system felt about their decision years afterward.

The research showed an overwhelmingly positive response – the median satisfaction score was a 5 on a 5-point scale, the highest possible rating. The median decision regret score was 0.0 on a 100-point scale where lower scores mean less regret.

In another indirect measure of satisfaction, none of the patients in the study pursued a reversal of their mastectomy.

The study’s authors analyzed records for 235 patients and sent a survey to all of them; 139 responded. The 139 participants were between two to 20 years out from their procedure and the median age was 27 years old.

The participants were asked a series of questions that have been validated for their ability to measure satisfaction and regret in other medical and surgical conditions.

“We wanted to make sure that our questions would produce quality data that could be compared to other conditions when looking at satisfaction and regret levels for gender-affirming care,” said Megan Lane, MD, a plastic surgery resident at Michigan Medicine and co-lead author of the paper.

Due to low dissatisfaction numbers, it wasn’t possible to look at any reasons for or factors related to dissatisfaction with gender-affirming mastectomy.

Lane and her co-authors say new survey tools are needed to explore this more thoroughly.

Additional authors include Lauren Bruce, B.A.; Andrew Bolze, B.A.; Maria Ibarra, M.S.; Gaines Blasdel, B.S.; from the University of Michigan Medical School, Ann Arbor. Alexander N. Khouri, M.D.; Jennifer B. Hamill, M.P.H.; Jessica J. Hsu, M.D., Ph.D.; Edwin G. Wilkins, M.D.; Megan Lane, M.D., M.S. from the Section of Plastic Surgery, University of Michigan, Ann Arbor. Shokoufeh Khalatbari, M.S. from the Michigan Insititute for Clinical Health Research, Ann Arbor, Michigan. Shane D. Morrison, M.D., M.S. from the University of Washington, Seattle, Washington.

This study was funded through the Plastic Surgery Foundation Pilot Grant Program. Biostatistical support was funded through the National Center for Advancing Translational Sciences via the Michigan Institute for Clinical and Health Research.

In an invited commentary on the paper, a trio of authors from Rush University write, 'In gender-affirming surgery, concerns regarding the potential for regret are often used to deny or limit access to medically necessary care. However, when rates of regret in gender-affirming surgery are compared with other surgical interventions, the results are striking.'"

Paper cited: “Long-Term Regret and Satisfaction With Decision Following Gender-Affirming Mastectomy,” JAMA Surgery. 10.1001


More Articles About:

Basic Science and Laboratory Research Gender Transgender Services Demographics Lab Notes
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Father comforts sick child
News Release

15 years of data will help uncover how flu spreads—and how to reduce its impact

$14.2-million NIH award to University of Michigan funds research to untangle intricacies of person-to-person flu transmission—and reduce illness, deaths, economic losses
Michelle Hastings, Ph.D. and lab member look at molecule on computer screen.
News Release

$3.9 million NIH grant to fuel U-M effort to develop first targeted therapy for fatal childhood brain disorder

A team led by Dr. Michelle Hastings will advance a new RNA-based medicine for the most common form of CLN3 Batten disease toward clinical trials
A stylized digital image of an X-ray of a human skeleton superimposed on a strand of DNA
Health Lab

Bigger data reveals the second, third and fourth switches controlling a gene

A University of Michigan study reveals the untapped potential of the NIH-sponsored Trans-Omics for Precision Medicine, or TOPMed, program.
Medicaid magnifying glass
Health Lab

What’s changing in Medicaid and what can you do?

With eligibility rules for people with lower incomes changing in every state, it’s important to stay up to date, seek trustworthy sources and not fall for misinformation
layers of skin pink to yellow
Health Lab

Study outlines a new framework for direct cell reprogramming

In a new paper published in the journal iScience, Lindsey Muir, Ph.D. and her lab at Michigan Medicine propose a framework for direct cell reprogramming.
cells close up blue and green background microscope
Health Lab

Engineered nanoparticles sensitize gliomas to radiotherapy

University of Michigan researchers discovered a new pathway that sensitizes mIDH1 gliomas to radiation in human and mouse mIDH1 glioma cells and mouse models, paving the way for phase 1 clinical trials in humans